1009-0460
2015 Issue 8
Downregulation of miR-23a overcomes gefitinib resistance in non-small cell lung cancer cell with epidermal growth factor receptor mutation
WANG Jiying;,CAI Yong;,BAI Chong;
WANG Jiying;,CAI Yong;,BAI Chong;
..............page:673-678
Effect of siRNA targeting RPL6 gene on the proliferation and apoptosis of human cervical cancer HeLa cells
YAN Feng;,XI Yanni;
YAN Feng;,XI Yanni;
..............page:679-684
Effect of the mTOR inhibitor everolimus on the malignant behavior of cervical cancer SiHa cells
WU Qiufang;,TANG Zhouzhou;,ZHANG Dingfu;
WU Qiufang;,TANG Zhouzhou;,ZHANG Dingfu;
..............page:685-689
Expressions of CD133 and Ki-67 in giant cell tumor of bone and their clinical significance
LIU Guangfei;,WANG Lu;,LI Yong;,CHENG Cai;
LIU Guangfei;,WANG Lu;,LI Yong;,CHENG Cai;
..............page:690-693
Expressions and clinical significance of STOML2 and TRIM25 in hepatocellular carcinoma
JIN Hongyan;,HE Wei;,WEI Zexiong;
JIN Hongyan;,HE Wei;,WEI Zexiong;
..............page:694-698
The correlation of HER-2 gene amplification and Ki-67 protein expression in gastric cancer
LIU Ping;,BO Haiji;
LIU Ping;,BO Haiji;
..............page:699-703
Analysis of differences of FIGO staging and surgical staging and risk factors of lymph node metastasis of cervical cancer
SUN Ruirui;,HUERXIDAN Niyazi;,ZHAO Huarong;,ZHANG Lei;,REHEMAN Yiming;,BAO Yongxing;
SUN Ruirui;,HUERXIDAN Niyazi;,ZHAO Huarong;,ZHANG Lei;,REHEMAN Yiming;,BAO Yongxing;
..............page:704-708
Effect of transcatheter arterial chemoembolization on the circulating tumor cells number and the vascular endothelial growth factor concentration in patients with hepatocellular carcinoma
LI Qimin;,QIAO Huiping;,MU Yongxu;,YAN Ruiqiang;,HE Junfeng;,HU Xiaoyan;
LI Qimin;,QIAO Huiping;,MU Yongxu;,YAN Ruiqiang;,HE Junfeng;,HU Xiaoyan;
..............page:709-712
Effect observation of recombinant human granulocyte colony-stimulating factor on treating chemotherapy-induced oral ulcer
LIU Guojian;,LU Binbin;,WANG Zhaoxia;,WANG Keming;
LIU Guojian;,LU Binbin;,WANG Zhaoxia;,WANG Keming;
..............page:713-717
A clinical study of aprepitant for prevention of chemotherapy-induced vomiting induced by highly-moder-ately emetogenic chemotherapy
CHEN Cheng;,WANG Xiaohua;,DENG Rong;,MEI Jingfeng;,XU Hongxia;
CHEN Cheng;,WANG Xiaohua;,DENG Rong;,MEI Jingfeng;,XU Hongxia;
..............page:718-721
Effect of oxycodone controlled-release tablets in titration of moderate or severe cancer pain for background
YUAN Lingyan;,LIU Ke;,WANG Zhan;,LOU Cheng;,QIAN Jianxin;,WANG Jiejun;
YUAN Lingyan;,LIU Ke;,WANG Zhan;,LOU Cheng;,QIAN Jianxin;,WANG Jiejun;
..............page:722-725
The relationship between multi-mutation of HBV X gene and hepatocellular carcinoma
YANG Wei;,LI Zengcai;,NI Xiuying;,WANG Tao;
YANG Wei;,LI Zengcai;,NI Xiuying;,WANG Tao;
..............page:726-729
Application of adipofascial flaps in mammoplasty
ZHAO Kaihua;,YAN Zheng;,TAN Zhengshuai;,GONG Lei;,WANG Binggao;,LIU Songling;
ZHAO Kaihua;,YAN Zheng;,TAN Zhengshuai;,GONG Lei;,WANG Binggao;,LIU Songling;
..............page:730-733
Role of neoadjuvant chemotherapy in the maintenance of fertility on young patients with ovarian yolk sac tumor
WU Yuzhong;,PENG Surong;,CHEN Xiaoxiang;,SHEN Yang;
WU Yuzhong;,PENG Surong;,CHEN Xiaoxiang;,SHEN Yang;
..............page:734-737
The pathogenesis and preventive measures of reintubation in patients undergoing esophagectomy
ZHOU Yuan;,WANG Dong;,HAN Kaibao;,XU Gang;,ZHANG Jianfeng;,LIU Hong;
ZHOU Yuan;,WANG Dong;,HAN Kaibao;,XU Gang;,ZHANG Jianfeng;,LIU Hong;
..............page:738-740
Dosimetric evaluation of helical tomotherapy and two types of volumetric modulated arc therapy for malig-nant pleural mesothelioma
ZHANG Fuli;,XU Weidong;,JIANG Huayong;,WANG Yadi;,GAO Junmao;,LIU Qingzhi;
ZHANG Fuli;,XU Weidong;,JIANG Huayong;,WANG Yadi;,GAO Junmao;,LIU Qingzhi;
..............page:741-744
Advances in the correlation between SIRT6 and tumor
MA Lanjing;,MA Yubo;,ZHANG Song;,NIE Yongzhan;
MA Lanjing;,MA Yubo;,ZHANG Song;,NIE Yongzhan;
..............page:745-749
Clinical development of poly(ADP-ribose) polymerase inhibitors
WANG Junhui;,CHEN Jianxin;,XIE Fangwei;
WANG Junhui;,CHEN Jianxin;,XIE Fangwei;
..............page:750-754
The inhibitory effects of the liver X receptor agonists on the EGFR associated signal pathway
LIU Siwen;,FENG Jifeng;
LIU Siwen;,FENG Jifeng;
..............page:755-759
huan ying ding yue lin chuang zhong liu xue za zhi
lin chuang zhong liu xue za zhi bian ji bu ;
lin chuang zhong liu xue za zhi bian ji bu ;
..............page:759-759
New progress of the diagnosis technology of hilar cholangiocarcinoma
MA Xiaolin;,CHEN Jianping;
MA Xiaolin;,CHEN Jianping;
..............page:760-764
guan yu can kao wen xian de yin yong yao qiu
lin chuang zhong liu xue za zhi bian ji bu ;
lin chuang zhong liu xue za zhi bian ji bu ;
..............page:764-764
gan dan guan xi bao ai he bing shang qiang jing mai zong he zheng 1 li
liao feng ;, hua hai qing ;, qin shu zuo ;
liao feng ;, hua hai qing ;, qin shu zuo ;
..............page:765-766
pei mei qu sai chang qi dan yao wei chi zhi liao e xing fu mo jian pi liu 1 li
shi yan long ;, bi jing wang ;
shi yan long ;, bi jing wang ;
..............page:767-768